Company intelligence / Profile preview
Vita Therapeutics
Baltimore, Maryland, United Statesvitatx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company has shown impressive pre-clinical curative results in muscular dystrophy using induced pluripotent stem cells to derive human satellite cells that can sustainably repair and replace muscle over time. As of 2022, they were preparing an IND application for their lead therapy.
- Therapeutic areas
- OncologyNeurology
- Modalities
- Stem cell therapyCell therapyGene therapyAAV based gene therapyExosomes
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Vita Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vita Therapeutics.